CV SCHEDULE 13G/A: SEC filing
An amendment to a Schedule 13G was
Filed with the SEC on · accession 0001009165-26-000011
CV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 4, 2026. An amendment to a Schedule 13G was filed regarding CapsoVision, Inc. (CV).
Summary of the filing
An amendment to a Schedule 13G was filed regarding CapsoVision, Inc. (CV). The filing indicates a change in a passive institutional investor's ownership position.
Key details
✦ Ask GOAX AI about this filing — what it means for CV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CV?
Click hereFrequently asked questions
What did CV file with the SEC on Nov 4, 2026?
CV filed a SCHEDULE 13G/A (SEC filing). An amendment to a Schedule 13G was filed regarding CapsoVision, Inc. (CV). The filing indicates a change in a passive institutional investor's ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other CV SEC filings
- 8-K · Fda approvalSep 28, 2026
- 8-K · Secondary offeringSep 18, 2026
- 424B5 · Secondary offeringSep 18, 2026
- 424B5 · Secondary offeringAug 21, 2026
- 8-K · Secondary offeringAug 18, 2026
- S-3 · Shelf registrationAug 13, 2026
- 8-K · Secondary offeringAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · SEC filingJul 2, 2026
- 8-K · Board changeJun 12, 2026
Get alerts when CV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days